1910 Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 16

1910 General Information

Description

Developer of a drug discovery platform intended to offer small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. The company's platform offers new end-to-end drug discovery and development processes that must be reimagined from the ground up using AI, enabling clients to improve productivity and decrease failure rates across the pharmaceutical development process.

Contact Information

Website
www.1910.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 451 D Street
  • Suite 905
  • Boston, MA 02210
  • United States
+1 (508)
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 451 D Street
  • Suite 905
  • Boston, MA 02210
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

1910 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 31-Oct-2024 Completed Generating Revenue
4. Grant 29-Jun-2021 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC (Series A) 23-Mar-2021 $25.7M $25.8M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2019 $125K $125K Completed Startup
To view 1910’s complete valuation and funding history, request access »

1910 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-6
Series A-5
Series A-4
Series A-3
Series A-2 476,321 $0.000100 8% $1.36 $1.36 1x $1.36 2.83%
Series A-1 4,516,639 $0.000100 8% $4.87 $4.87 1x $4.87 26.83%
To view 1910’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

1910 Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform intended to offer small and large molecule drug discovery with a multimodal AI pl
Discovery Tools (Healthcare)
Boston, MA
43 As of 2026

Palo Alto, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

1910 Competitors (14)

One of 1910’s 14 competitors is BioMap, a Venture Capital-Backed company based in Palo Alto, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioMap Venture Capital-Backed Palo Alto, CA
Atomic AI Venture Capital-Backed San Francisco, CA
Terray Therapeutics Venture Capital-Backed Monrovia, CA
Exscientia Formerly VC-backed Oxford, United Kingdom
PostEra Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 14 competitors. Get the full list »

1910 Patents

1910 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026117739-A1 Keto amide compounds as calpain inhibitors Pending 27-Nov-2024
US-20250257051-A1 Substituted pyrimidine compounds as tyk2 inhibitors Pending 28-Jul-2022
WO-2024026430-A1 Substituted pyrimidine compounds as tyk2 inhibitors Inactive 28-Jul-2022
FR-2853396-A1 Electronic photophore for reproducing natural flame, has leds supplied by rechargeable batteries, control card controlling supply of led, and microprocessor placed on card for controlling ignition and extinction of led Inactive 01-Apr-2003 F21S9/02

1910 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

1910 Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accenture Technology Ventures Corporate Venture Capital Minority
Foobar Family Office Minority
NVIDIA Corporation Minority
1945 Capital Family Office Minority
Apollo (VC) Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

1910 FAQs

  • When was 1910 founded?

    1910 was founded in 2018.

  • Where is 1910 headquartered?

    1910 is headquartered in Boston, MA.

  • What is the size of 1910?

    1910 has 43 total employees.

  • What industry is 1910 in?

    1910’s primary industry is Discovery Tools (Healthcare).

  • Is 1910 a private or public company?

    1910 is a Private company.

  • What is 1910’s current revenue?

    The current revenue for 1910 is .

  • How much funding has 1910 raised over time?

    1910 has raised $25.8M.

  • Who are 1910’s investors?

    Accenture Technology Ventures, Foobar, NVIDIA, 1945 Capital, and Apollo (VC) are 5 of 16 investors who have invested in 1910.

  • Who are 1910’s competitors?

    BioMap, Atomic AI, Terray Therapeutics, Exscientia, and PostEra are some of the 14 competitors of 1910.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process